Stay updated on TNBC Neoadjuvant and Adjuvant Pembrolizumab Clinical Trial
Sign up to get notified when there's something new on the TNBC Neoadjuvant and Adjuvant Pembrolizumab Clinical Trial page.

Latest updates to the TNBC Neoadjuvant and Adjuvant Pembrolizumab Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedUpdated the Italy site listing by changing Macerata, Italy, 62100 to Province of Macerata, Italy, 62100, adding a more precise regional designation to the trial site. The change also introduces a new version tag, Revision: v3.5.4.SummaryDifference0.1%

- Check18 days agoChange DetectedTaiwan site location updated to Taoyuan, Taiwan (postal code 333), replacing Taoyuan District in the location list.SummaryDifference0.0%

- Check25 days agoChange DetectedThe page now displays Revision: v3.5.3, replacing Revision: v3.5.2. This updates the page's revision history to reflect the latest release.SummaryDifference0.0%

- Check39 days agoChange DetectedAdded a new publication entry for KEYNOTE-522 Japan Subgroup Analysis (Cancer Sci. 2026 Apr;117(4):1106-1116; doi:10.1111/cas.70307). The prior entry listing 'Online ahead of print' was replaced with the April 2026 citation.SummaryDifference0.0%

- Check61 days agoChange DetectedLocation label updated from Napoli, Italy 80131 to Naples, Italy 80131 and version updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check75 days agoChange DetectedThe study record metadata now shows revision v3.4.3, replacing the previous v3.4.2.SummaryDifference0.0%

Stay in the know with updates to TNBC Neoadjuvant and Adjuvant Pembrolizumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the TNBC Neoadjuvant and Adjuvant Pembrolizumab Clinical Trial page.